The total return over the past 12 months is +54.67% vs. +16.94% for the S&P 500. So far it's up -19.51% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +54.67% | +25.71% | (14.84%) | N/A | N/A | N/A |
| Total Return CAGR | +54.67% | +25.71% | (14.84%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Greenwich LifeSciences, Inc. (GLSI)
| Year | Start price | End price | GLSI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $21.01 | $16.91 | (19.51%) | +14.51% | (34.02%) |
| 2025 | $11.23 | $21.01 | +87.09% | +17.72% | +69.37% |
| 2024 | $10.52 | $11.23 | +6.75% | +24.89% | (18.14%) |
| 2023 | $15.20 | $10.52 | (30.79%) | +26.19% | (56.98%) |
| 2022 | $24.33 | $15.20 | (37.53%) | (18.17%) | (19.36%) |
| 2021 | $36.47 | $24.33 | (33.29%) | +28.74% | (62.03%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
